Jack J Olney1, Jeffrey W Eaton2, Paula Braitstein3,4, Joseph W Hogan5, Timothy B Hallett2. 1. Centre for Health Economics & Policy Innovation, Imperial College Business School, London, UK. 2. Department of Infectious Disease Epidemiology, Imperial College London, London, UK. 3. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. 4. Department of Medicine, College of Health Sciences, School of Medicine, Moi University, Eldoret, Kenya. 5. Department of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
We appreciate the letter in response to our article “Optimal timing of HIV home‐based counselling and testing rounds in Western Kenya 1.” The authors appraise the assumptions made by the model and question whether the modelled HBCT programme in western Kenya could be improved 2.As the authors are aware, high prevalence settings often require active outreach to identify a meaningful proportion of the infected population 3. However, timely linkage to care following diagnosis remains a challenge 4. Several studies are looking at innovative means of addressing this, including the use of peer navigators 5, mHealth initiatives 6, and same‐day ART start 7.Meanwhile, a different ‐ but still valid ‐ question concerns how best to use an existing programme, in this case through repeating it to test more people. The model is based on real data from AMPATH which arguably makes it conclusions better suited to policy than arguments based on hypothetical extrapolations. It was necessary to make assumptions, and these were not with the intention of being cautiously conservative about the impact of the programme.Further model analyses could indeed compare the impact of different types of HBCT programme, as well as assessing ancillary benefits such as knowledge transfer to the community and NCD testing.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JJO and TBH drafted the initial version of the letter. JWE, PB and JWH reviewed and provided revisions to the draft prior, before JJO circulated the finalized letter for approval from all authors prior to submission.
Authors: Samson Ndege; Sierra Washington; Alice Kaaria; Wendy Prudhomme-O'Meara; Edwin Were; Monica Nyambura; Alfred K Keter; Juddy Wachira; Paula Braitstein Journal: PLoS One Date: 2016-01-19 Impact factor: 3.240
Authors: Kalpana Sabapathy; Constance Mubekapi-Musadaidzwa; Chama Mulubwa; Ab Schaap; Graeme Hoddinott; Anne Stangl; Sian Floyd; Helen Ayles; Sarah Fidler; Richard Hayes Journal: J Int AIDS Soc Date: 2017-12 Impact factor: 5.396
Authors: Pooja Shah; Mia Kibel; David Ayuku; Regina Lobun; John Ayieko; Alfred Keter; Allan Kamanda; Dominic Makori; Collins Khaemba; Anthony Ngeresa; Lonnie Embleton; Katherine MacDonald; Edith Apondi; Paula Braitstein Journal: AIDS Behav Date: 2019-04